Metropolitan Life Insurance Company (MetLife)’s CSX Corp CSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-79,703
Closed -$2.95M 523
2024
Q1
$2.95M Sell
79,703
-734
-0.9% -$26.8K 0.13% 140
2023
Q4
$2.79M Sell
80,437
-2,574
-3% -$82K 0.13% 136
2023
Q3
$2.55M Sell
83,011
-5,588
-6% -$177K 0.13% 135
2023
Q2
$3.02M Sell
88,599
-5,437
-6% -$172K 0.15% 119
2023
Q1
$2.82M Sell
94,036
-25,197
-21% -$775K 0.14% 128
2022
Q4
$3.69M Sell
119,233
-8,248
-6% -$248K 0.17% 121
2022
Q3
$3.4M Sell
127,481
-3,479
-3% -$108K 0.16% 126
2022
Q2
$3.81M Sell
130,960
-5,913
-4% -$193K 0.17% 123
2022
Q1
$5.13M Sell
136,873
-116,538
-46% -$4.12M 0.18% 108
2021
Q4
$9.53M Sell
253,411
-9,426
-4% -$332K 0.13% 122
2021
Q3
$7.82M Sell
262,837
-10,778
-4% -$345K 0.11% 142
2021
Q2
$8.78M Sell
273,615
-6,045
-2% -$199K 0.12% 130
2021
Q1
$8.99M Sell
279,660
-14,604
-5% -$446K 0.13% 127
2020
Q4
$8.9M Sell
294,264
-15,438
-5% -$443K 0.13% 126
2020
Q3
$8.02M Sell
309,702
-13,989
-4% -$345K 0.14% 130
2020
Q2
$7.52M Sell
323,691
-59,655
-16% -$1.32M 0.13% 134
2020
Q1
$7.32M Sell
383,346
-4,119
-1% -$96.2K 0.15% 125
2019
Q4
$9.35M Sell
387,465
-6,576
-2% -$156K 0.15% 124
2019
Q3
$9.1M Sell
394,041
-2,415
-0.6% -$56.2K 0.15% 115
2019
Q2
$10.2M Buy
396,456
+23,208
+6% +$598K 0.17% 102
2019
Q1
$9.31M Sell
373,248
-29,163
-7% -$675K 0.17% 103
2018
Q4
$8.33M Sell
402,411
-8,481
-2% -$195K 0.17% 102
2018
Q3
$10.1M Sell
410,892
-36,444
-8% -$868K 0.17% 101
2018
Q2
$9.51M Sell
447,336
-62,325
-12% -$1.28M 0.15% 116
2018
Q1
$9.46M Sell
509,661
-9
-0% -$168 0.13% 118
2017
Q4
$9.35M Sell
509,670
-889,113
-64% -$15.7M 0.12% 121
2017
Q3
$25.3M Sell
1,398,783
-35,760
-2% -$614K 0.16% 110
2017
Q2
$26.1M Buy
1,434,543
+57,765
+4% +$990K 0.18% 106
2017
Q1
$21.4M Sell
1,376,778
-35,286
-2% -$538K 0.15% 130
2016
Q4
$16.9M Sell
1,412,064
-58,182
-4% -$652K 0.12% 156
2016
Q3
$14.9M Sell
1,470,246
-24,900
-2% -$235K 0.11% 176
2016
Q2
$13M Sell
1,495,146
-63,924
-4% -$557K 0.1% 201
2016
Q1
$13.4M Sell
1,559,070
-50,139
-3% -$407K 0.1% 185
2015
Q4
$13.9M Sell
1,609,209
-12,531
-0.8% -$114K 0.11% 182
2015
Q3
$14.5M Sell
1,621,740
-36,060
-2% -$354K 0.1% 183
2015
Q2
$18M Buy
1,657,800
+29,658
+2% +$344K 0.13% 157
2015
Q1
$18M Sell
1,628,142
-29,451
-2% -$339K 0.13% 157
2014
Q4
$20M Sell
1,657,593
-34,368
-2% -$402K 0.14% 142
2014
Q3
$18.1M Sell
1,691,961
-32,754
-2% -$338K 0.13% 156
2014
Q2
$17.7M Sell
1,724,715
-152,529
-8% -$1.49M 0.12% 168
2014
Q1
$18.1M Sell
1,877,244
-39,720
-2% -$368K 0.13% 163
2013
Q4
$18.4M Sell
1,916,964
-76,887
-4% -$689K 0.13% 156
2013
Q3
$17.1M Sell
1,993,851
-18,672
-0.9% -$157K 0.13% 152
2013
Q2
$15.6M Buy
+2,012,523
New +$16.5M 0.12% 153

Other funds holding CSX

Metropolitan Life Insurance Company (MetLife)'s CSX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of CSX Corp (CSX) in Q2 2024, closing a stake of 79,703 shares — an estimated $2.95M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CSX in Q2 2013 and held it in 44 quarters. The position peaked at $26.1M in Q2 2017. 1,659 funds tracked by Wall St. Rank hold CSX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining CSX Corp position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 79,703 CSX Corp shares in Q2 2024, an estimated $2.95M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in CSX Corp in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s CSX Corp position peaked at $26.1M in Q2 2017.
  • 1,659 funds tracked by Wall St. Rank held CSX Corp as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.